A case report of multifocal colonic mucinous adenocarcinoma with peritoneal and omental metastases in a young female

Girija1*, Thanaseeli2, Esthar Rani3

1Nursing Supervisor, Kauvery Hospital, Tennur, Trichy, Tamil Nadu

2Assistant Nursing Superintendent, Kauvery Hospital, Tennur, Trichy, Tamil Nadu

3Nursing Superintendent, Kauvery Hospital, Tennur, Trichy, Tamil Nadu

*Correspondence

Abstract: Colorectal cancer, although more common in older adults, can also occur in younger individuals. A 31-years-old female with no known comorbidities was diagnosed with multifocal colonic carcinoma involving the ascending and descending colon. Histopathological examination revealed poorly differentiated mucinous adenocarcinoma, while imaging demonstrated peritoneal and omental metastases with ascites, confirming stage IV disease. The patient was admitted for the second cycle of FOLFOX chemotherapy (oxaliplatin, leucovorin, and 5-fluorouracil). This case highlights the occurrence of advanced colorectal cancer in young individuals and emphasizes the importance of early diagnosis, accurate staging, and individualized oncological management.

Introduction

Colorectal cancer is one of the most diagnosed malignancies worldwide, arising from the epithelial lining of the colon or rectum. Although its incidence increases with age, it can also occur in younger adults and may present with advanced disease. Mucinous adenocarcinoma is a distinct histological subtype of colorectal cancer characterized by abundant extracellular mucin production. Its clinical behaviour and prognosis are influenced by tumour stage, histological features, metastatic spread, and response to treatment. Advanced colorectal cancer may involve regional lymph nodes, the peritoneum, and omentum, sometimes accompanied by ascites and distant metastases. Accurate diagnosis and staging require clinical assessment, radiological investigations, and histopathological confirmation.

This case report presents a 31-year-old female diagnosed with stage IV multifocal colonic mucinous adenocarcinoma involving the ascending and descending colon, with peritoneal and omental metastases.

Case Presentation

A 31-year-old female with no known comorbidities was diagnosed with multifocal colonic carcinoma involving the ascending and descending colon. Diagnostic laparoscopy, Peritoneal Cancer Index (PCI) assessment, and biopsy were performed. Histopathological examination of the descending colon lesion confirmed poorly differentiated mucinous adenocarcinoma. Subsequent imaging revealed extensive colonic involvement with peritoneal and omental metastatic deposits. Following evaluation by the medical oncology team, the patient was diagnosed with stage IV colonic carcinoma and admitted for the second cycle of FOLFOX chemotherapy.

Diagnostic Investigations

Histopathological Examination: Biopsy of the descending colon lesion revealed poorly differentiated mucinous adenocarcinoma, confirming the diagnosis of malignancy.

Contrast-Enhanced CT of the Abdomen and Pelvis

The CT findings included:

  • Circumferential enhancing wall thickening involving the ascending colon.
  • Mild pericolonic fat stranding.
  • Multiple enlarged pericolonic lymph nodes.
  • Moderate ascites.
  • Diffuse nodular omental thickening, suggestive of peritoneal metastatic involvement.
  • No definite pelvic mass or liver lesion identified.

Whole-Abdomen Ultrasonography: The ultrasound examination revealed splenomegaly and findings suggestive of cystitis.

FDG PET/CT: The PET/CT findings demonstrated:

  • Metabolically active circumferential mural thickening involving the distal ascending colon, hepatic flexure, and proximal transverse colon.
  • Enlarged metabolically active perilesional lymph nodes, suspicious for metastatic involvement.
  • Diffuse metabolically active omental thickening with moderate ascites, suggestive of peritoneal metastases.
  • A focal metabolically active lesion in the left ovary, suspicious for metastatic involvement.
  • A low-grade metabolically active subpleural nodular lesion in the left lower lung lobe, requiring clinical correlation.
  • No other metabolically active visceral or skeletal lesions identified.

The combined histopathological and radiological findings supported the diagnosis of advanced multifocal colonic mucinous adenocarcinoma with peritoneal and omental metastatic involvement.

Treatment and Management

The patient received the second cycle of FOLFOX chemotherapy under medical oncology supervision.

Chemotherapy Regimen

The documented chemotherapy regimen included:

  • Oxaliplatin: 80 mg intravenously over 2 hours.
  • Leucovorin: 350 mg intravenously over 2 hours.
  • 5-Fluorouracil: 2,000 mg by continuous intravenous infusion over 24 hours using an infusion pump through a central venous line.

Supportive Medication

Supportive medications prescribed at discharge included:

  • Aprepitant
  • Olanzapine
  • Dexamethasone
  • Pantoprazole
  • Laxative

These medications were administered according to the treating oncologist’s instructions.

Discharge and Follow-up

The patient was discharged in fair general condition with stable vital signs. Follow-up was planned with complete blood count (CBC), renal function tests (RFT), and liver function tests (LFT).

Discussion

The nursing management of patients with advanced colorectal cancer requires comprehensive assessment, safe chemotherapy administration, continuous monitoring, and supportive care. In this case, the patient received FOLFOX chemotherapy, requiring careful monitoring for treatment-related complications such as nausea, vomiting, diarrhoea, mucositis, myelosuppression, and peripheral neuropathy. Nurses play a vital role in verifying chemotherapy orders, ensuring safe administration, monitoring infusion pumps and central venous access. Patient education regarding infection prevention, nutritional support, symptom recognition, and timely reporting of adverse effects is essential. Regular clinical assessment and laboratory monitoring help identify complications early and support continuity of care. This case highlights the importance of oncology nursing in promoting chemotherapy safety, managing treatment-related toxicities, providing psychological support, and improving patients’ quality of life.

Conclusion

This case highlights the occurrence of advanced multifocal colonic mucinous adenocarcinoma in a young female and emphasizes the importance of accurate diagnosis, timely treatment, and multidisciplinary care. Oncology nurses play a crucial role in ensuring safe chemotherapy administration, providing patient education, and offering psychological support. Comprehensive nursing care, regular monitoring, and effective patient counselling are essential to promote treatment safety, improve quality of life, and support continuity of care in patients with advanced colorectal cancer.

References

  1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660.
  2. Dharwadkar P, Zaki TA, Murphy CC. Colorectal cancer in younger adults. Hematol Oncol Clin North Am. 2022;3:449–470. doi:10.1016/j.hoc.2022.02.005.
  3. Luo C, Cen S, Ding G, Wu W. Mucinous colorectal adenocarcinoma: clinical pathology and treatment options. Cancer Commun (Lond). 2019. doi:10.1186/s40880-019-0361-0.
  4. Cervantes A, Adam R, Roselló S, Arnold D, Normanno N, Taïeb J, et al. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023:10–32. doi:10.1016/j.annonc.2022.10.003.
  5. Siegel RD, LeFebvre KB, Temin S, Evers A, Barbarotta L, Bowman RM, et al. Antineoplastic therapy administration safety standards for adult and pediatric oncology: ASCO-ONS Standards. Oncol Nurs Forum. 2024;51(4):297–320. doi:10.1188/24.ONF.297-320.
Kauvery Hospital